drugset / Trial / NCT02382328

Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Carpal Tunnel Syndrome Undergoing Surgical Release

NCT02382328

Phase 2 Completed 40 enrolled Hospital Civil de Guadalajara
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to determine the effectiveness of use Alpha lipoic acid before and after surgical release of carpal tunnel syndrome. Controlled Clinical trial.

Timeline

Start
2016-02
Primary completion
2016-06
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject alpha-lipoic acid Small molecule 600 mg Oral